James W. Lohr - Concepedia

Author

James W. Lohr

University at Buffalo, State University of New York ORCID

Also Known As

J LOHR, J Lohr, J Löhr, J W Lohr, J. Lohr, J. Löhr, J. W. Lohr, J.W. Lohr, James Lohr, James W Lohr

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

University at Buffalo, State University of New York Buffalo VA Medical Center United States Department of Veterans Affairs Roswell Park Comprehensive Cancer Center University of Kansas Medical Center

About

James W. Lohr is an author at University at Buffalo, State University of New York specializing in medicine, nephrology, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	23	957
2	Health Sciences	2	2	98
3	Engineering	1	1	128
4	Natural Sciences	1	1	13
5	Public Health	1	1	14

James W. Lohr

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Preoperative Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Is Associated with Increased Risk for Acute Kidney Injury after Cardiovascular Surgery Pradeep Arora, Srini Rajagopalam, Rajiv Ranjan, Clinical Journal of the American Society of Nephrology	2008	245
A Clinical Index to Predict Survival in Acute Renal Failure Patients Requiring Dialysis James W. Lohr, Michael McFarlane, Jared J. Grantham American Journal of Kidney Diseases HemodialysisRenal FunctionRenal DiseaseMedicineKidney Failure	1988	129
Isovolumetric regulation of isolated S2 proximal tubules in anisotonic media. James W. Lohr, Jared J. Grantham Journal of Clinical Investigation Sudden AlterationEngineeringCell Volume MaintenanceCytoskeletonOptogenetics	1986	128
Proton pump inhibitors are associated with increased risk of development of chronic kidney disease Pradeep Arora, Anu Gupta, Mojgan Golzy, BMC Nephrology	2016	125
Organic osmolytes in acute hyponatremia Richard H. Sterns, J. E. Baer, S. Ebersol, American Journal of Physiology-Renal Physiology Animal PhysiologySevere HyponatremiaElectrolyte DisorderLiquid NitrogenBiochemistry	1993	91
Minimizing hemorrhagic complications in dialysis patients. James W. Lohr, Steve J. Schwab Journal of the American Society of Nephrology DialysisDialysis TherapyRegional Citrate AnticoagulationDialysis PatientsThrombosis	1991	83
Effect of acute and chronic hypernatremia on myoinositol and sorbitol concentration in rat brain and kidney James W. Lohr, James H. McReynolds, Thomas Grimaldi, Life Sciences Sodium HomeostasisMedicinePhysiologyChronic HypernatremiaNeuroscience	1988	71
Eculizumab therapy for gemcitabine induced hemolytic uremic syndrome: case series and concise review. Omar Al Ustwani, James W. Lohr, Grace K. Dy, PubMed ImmunohematologyUrologyAutoimmune DiseaseSclerodermaHematology	2014	69
Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case report Anubha Bharthuar, Lori Egloff, Joanne Becker, Cancer Chemotherapy and Pharmacology UrologyPancreatic CancerRituximab-based TherapyMetastatic Pancreatic AdenocarcinomaMedicine	2008	49
Renal papillary necrosis in a patient with sickle cell trait. Gholam Zadeii, James W. Lohr Journal of the American Society of Nephrology GlomerulonephritisUrologyGross HematuriaMedicineRenal Pathology	1997	49

Page 1